Selecta Biosciences, Inc. Company Profile

23:28 EDT 27th July 2015 | BioPortfolio

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta’s fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes. Selecta’s SVP™ platform technology is flexible to enable diverse vaccines and the company has created targeted antigen-specific Synthetic Vaccine Particles (tSVP™) and targeted antigen-specific tolerogenic Synthetic Vaccine Particles (t2SVP™).


News Articles [584 Associated News Articles listed on BioPortfolio]

Sanofi Exercises Option On 2nd Therapeutic Program With Selecta Biosciences

PARIS (dpa-AFX) - Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, said that, under the terms of an existin...

Selecta Biosciences, Genethon enter gene therapy pact

Selecta Biosciences and Genethon agreed to collaborate in the research and development of gene therapies to treat rare diseas -More- 

Sanofi exercises option on second program with Selecta Biosciences

US clinical-stage biopharma company Selecta Biosciences says that Sanofi has exercised its option to…

Sanofi, Selecta Biosciences extend partnership on synthetic vaccine particle technology

Sanofi, in relation to an existing collaboration, has exercised its option to an exclusive license to develop an immunotherapy for the treatment of celiac disease with Selecta Biosciences, a Watertown...

Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals

Selecta Biosciences looks to have found two new potential niches for its nanoparticle technology. The Watertown, MA-based company is announcing two deals this morning. First, Selecta said that Sanofi ...

Genethon, Selecta team up in gene therapies

Selecta Biosciences Inc. and Genethon will co-develop next-generation gene therapies.

Sanofi and Selecta partner to develop new immunotherapy for celiac disease

French drugmaker Sanofi has exercised its option with Selecta Biosciences for second exclusive licence to develop an immunotherapy to treat celiac disease.

Sanofi, Selecta broaden immunotherapy deal

Sanofi and Selecta Biosciences are broadening their immunotherapy collaboration, which began in 2012, with Sanofi exercising  -More- In 2014, 66% of Approved Drugs Earned Clearance Through A...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [126 Associated PubMed Articles listed on BioPortfolio]

Biosciences in nurse education: is the curriculum fit for practice? Lecturers' views and recommendations from across the UK.

This study aims to review the biosciences component of preregistration nursing programmes in higher education institutions across the UK through the experiences and perceptions of lecturers involved i...

Contents list.

Front cover.

Back cover.

Contents list.

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [313 Associated Companies listed on BioPortfolio]

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...

Selecta Biosciences, Inc. and Genethon

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Selecta Biosciences, Inc." on BioPortfolio

We have published hundreds of Selecta Biosciences, Inc. news stories on BioPortfolio along with dozens of Selecta Biosciences, Inc. Clinical Trials and PubMed Articles about Selecta Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selecta Biosciences, Inc. Companies in our database. You can also find out about relevant Selecta Biosciences, Inc. Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Biopharmaceuticals
Latest News Clinical Trials Research Drugs Reports Corporate
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Antibodies
Latest News Clinical Trials Research Drugs Reports Corporate
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record